This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Budgeting aids success by clarifying priorities, reducing waste, and creating a roadmap toward your desired financial outcomes.
19,451 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
At 62, he claimed social security against his advisor's warnings. Now, at 78, his roughly $900,000 portfolio suggests...
Imagine a world where chair kevin warsh takes the helm of the Fed under a Trump political backdrop. This article brea...
The Justice Department filed a federal civil rights lawsuit against Harvard, alleging leadership failed to curb antis...
A weekend meteor over New England, described as elephant-sized by NASA, created loud booms and sparked a fresh look a...
Ray Dalio’s Suez analogy returns to the headlines as markets weigh the U.S. risk of a reserve-currency shift and a we...
A Tokyo-based lender is weighing a potential Jefferies takeover, a move that could reshape cross-border banking and i...
A Manhattan bar tests risk hedging during the NBA Finals, using Kalshi to cover tabs if the Knicks win, after a costl...
Snap co-founder Evan Spiegel and Miranda Kerr are funding a California medical debt relief program, potentially wipin...
Startale Group has closed a $63 million Series A led by SBI Group and Sony Innovation Fund, accelerating its Strium L...
A celebrity-led passion project climbs to the top on Apple TV, proving that owning your story and diversifying income...
A troubling trend is rising where criminals recruit ordinary people through Telegram to intercept high-value deliveri...